Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

6 API Suppliers, 1 USDMF, 3 EU WC, 4 Listed Suppliers, $ API Reference Price

6 API Suppliers
1 USDMF
3 EU WC
4 Listed Suppliers
$ API Reference Price

INTERMEDIATES

6 Intermediates Suppliers

6 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

3 FDF Dossiers, 2 Europe, 1 Listed Dossiers

3 FDF Dossiers
2 Europe
1 Listed Dossiers

GLOBAL SALES INFORMATION

2 Finished Drug Prices

globalSalesInformation
2 Finished Drug Prices

MARKET PLACE

2 APIs

marketPlace
2 APIs

REF. STANDARDS & IMPURITIES

4 Others

otherSolutions
4 Others

Nuray Piribedil popup

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

API

FDF

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 3605-01-4, Trivastal, Trivastan, 2-(4-(benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)pyrimidine, Et-495, Eu-4200

Molecular Formula

C₁₆H₁₈N₄O₂

Molecular Weight

298.34 g/mol

InChI Key

OQDPVLVUJFGPGQ-UHFFFAOYSA-N

FDA UNII

DO22K1PRDJ

A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.

1 2D Structure

Piribedil

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]pyrimidine

2.1.2 InChI

InChI=1S/C16H18N4O2/c1-4-17-16(18-5-1)20-8-6-19(7-9-20)11-13-2-3-14-15(10-13)22-12-21-14/h1-5,10H,6-9,11-12H2

2.1.3 InChI Key

OQDPVLVUJFGPGQ-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C4=NC=CC=N4

2.2 Other Identifiers

2.2.1 UNII

DO22K1PRDJ

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Et 495

2. Et-495

3. Et495

4. Eu 4200

5. Eu-4200

6. Eu4200

7. Hydrochloride, Piribedil

8. Mesylate, Piribedil

9. Mono-hydrochloride, Piribedil

10. Piribedil Hydrochloride

11. Piribedil Mesylate

12. Piribedil Mono Hydrochloride

13. Piribedil Mono-hydrochloride

14. Piribendyl

15. Trivastal

2.3.2 Depositor-Supplied Synonyms

1. 3605-01-4

2. Trivastal

3. Trivastan

4. 2-(4-(benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)pyrimidine

5. Et-495

6. Eu-4200

7. Et 495

8. 2-(4-piperonyl-1-piperazinyl)pyrimidine

9. 2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]pyrimidine

10. Eu 4200

11. Do22k1prdj

12. 1-(2-pyrimidyl)-4-piperonylpiperazine

13. Pyrimidine, 2-(4-piperonyl-1-piperazinyl)-

14. Pyrimidine, 2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-

15. Piribedil (inn)

16. 2-(4-(3,4-methylenedioxybenzyl)piperazino)pyrimidine

17. 1-(3,4-methylenedioxybenzyl)-4-(2-pyrimidyl)piperazine

18. Ncgc00015857-05

19. 2-(4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl)pyrimidine

20. 2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]pyrimidine

21. Piribedil [inn]

22. Pyrimidine, 2-(4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl)-

23. Dsstox_cid_25188

24. Dsstox_rid_80735

25. Dsstox_gsid_45188

26. 2-[4-(2h-1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]pyrimidine

27. Cas-3605-01-4

28. Piribedile [dcit]

29. Piribedil [inn:dcf]

30. Piribedilum [inn-latin]

31. Piribedile

32. Piribedilum

33. Sr-01000076091

34. Trivastal (tn)

35. Einecs 222-764-6

36. Brn 0963637

37. Tocris-1031

38. Piribedil [mi]

39. Prestwick0_000980

40. Prestwick1_000980

41. Prestwick2_000980

42. Prestwick3_000980

43. Unii-do22k1prdj

44. Lopac-p-9233

45. Biomol-nt_000044

46. Gtpl49

47. Piribedil [mart.]

48. Cambridge Id 5268291

49. Piribedil [who-dd]

50. Lopac0_000965

51. Oprea1_061309

52. Oprea1_215383

53. Bspbio_001019

54. Schembl150101

55. Spbio_002930

56. Bpbio1_001121

57. Bpbio1_001269

58. Chembl1371770

59. Dtxsid9045188

60. Bdbm85092

61. Chebi:92833

62. 2-(4-benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-pyrimidine

63. Hms2089m17

64. Hms3885e19

65. Bcp10553

66. Nsc_4850

67. Tox21_110245

68. Mfcd00868264

69. S3656

70. Stl497889

71. Zinc19537374

72. Akos001309525

73. Tox21_110245_1

74. Ac-1051

75. Ccg-205045

76. Cs-8014

77. Db12478

78. Es-0016

79. Sdccgsbi-0050938.p003

80. Ncgc00015857-01

81. Ncgc00015857-02

82. Ncgc00015857-03

83. Ncgc00015857-04

84. Ncgc00015857-06

85. Ncgc00015857-07

86. Ncgc00015857-09

87. Ncgc00015857-16

88. Ncgc00024951-01

89. Ncgc00024951-02

90. Ncgc00024951-03

91. Hy-12707

92. Cas_3605-01-4

93. Sbi-0050938.p002

94. Cas-78213-63-5

95. Ab00514645

96. Ft-0610865

97. P2054

98. 2,5-diamino-4-(dimethylamino)-4-nitrostilbene

99. D07305

100. T72361

101. Ab00514645-19

102. 605p014

103. A823101

104. L000476

105. Q413976

106. Brd-k47936004-001-01-9

107. Brd-k47936004-003-03-1

108. Sr-01000076091-11

109. Z31240640

110. 1-(2-pyrimidyl)-4-(3,4-methylenedioxybenzyl)piperazine

111. 2-{4-[(1,3-benzodioxol-5-yl)methyl]piperazin-1-yl}pyrimidine

112. 2-{4-[(2h-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl}pyrimidine

113. 2-(4-(benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)pyrimidine Methanesulfonate

2.4 Create Date

2005-03-25

3 Chemical and Physical Properties

Molecular Formula	C₁₆H₁₈N₄O₂
Molecular Weight	298.34 g/mol
XLogP3	1.8
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	3
Exact Mass	298.14297583 g/mol
Monoisotopic Mass	298.14297583 g/mol
Topological Polar Surface Area	50.7 Å²
Heavy Atom Count	22
Formal Charge	0
Complexity	356
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Antiparkinson Agents

Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)

Dopamine Agonists

Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)

4.2 ATC Code

N04BC08

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355

N - Nervous system

N04 - Anti-parkinson drugs

N04B - Dopaminergic agents

N04BC - Dopamine agonists

N04BC08 - Piribedil

API SUPPLIERS